Please assess the completion status of the following clinical trial:

Trial Title: Thermogard™ Efficacy Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult males and non-pregnant females ages 18-70 with greater than 20% TBSA burns requiring excision and grafting and in need of a central venous catheter per ICU admission criteria.~* Patient or patient's surrogate must be able to verbalize understanding and willingness to participate in the study and provide written informed consent~Exclusion Criteria:~* Pregnancy. All females admitted to the burn ICU undergo routine serum hCG to determine pregnancy status. Those found to be pregnant will be excluded from entry into the study~* Burn patients enrolled in recombinant Factor VII study due to the theoretical increased risk for clot formation~* Basic and advanced enlisted trainees~* Age greater than 70 years old due to increased mortality rate among those severely burned~* Conditions which make placement of a central venous catheters a greater than normal risk (vascular anomalies, previous vascular surgery, etc.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Burn patients with \>20% TBSA burns scheduled to undergo debridement and grafting who will have placed the Thermogard™ central venous warming catheter by Alsius
- B (Type: ACTIVE_COMPARATOR): Burn patients with \>20% TBSA burns scheduled to undergo debridement and grafting who will have placed a central venous catheter as a part of their routine burn management

Based on this trial design, predict the completion outcome and termination type (if applicable).